10 mg Peptide Strength
Each vial contains a labeled strength of 10 mg of GHK-CU.
Copper Peptide / Skin and Tissue Peptide
Dragon Pharma Peptide Product
Dragon Pharma GHK-CU is supplied as a lyophilized powder in a 2 mL vial and contains the copper-binding peptide GHK-CU at a labeled strength of 10 mg. Product specifications, storage information, and available payment options are provided below.
Each vial contains a labeled strength of 10 mg of GHK-CU.
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
GHK-CU is a naturally occurring copper-binding peptide that has been investigated in preclinical research for its potential effects on tissue repair and related processes.
| Product name | GHK-CU 10 mg |
|---|---|
| Active substance | GHK-CU |
| Labeled strength | 10 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 10 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Other peptide options from the same product line include GHK-CU 50 mg as a higher-strength version of the same peptide, and BPC-157 5 mg, a peptide investigated for tissue repair research. These products differ in their peptide structure and the research applications for which they are used.
Science & Research
GHK-CU is a naturally occurring copper-binding peptide composed of three amino acids (glycine-histidine-lysine) with a copper ion bound to the peptide. It has been investigated in preclinical research for its potential role in tissue repair and other physiological processes.
GHK-CU is a tripeptide that is naturally present in human plasma and other tissues. Its levels have been observed to decline with age in some research.
The peptide binds copper ions, forming a copper-peptide complex. This interaction is believed to be important for the peptide's biological activity in preclinical research.
Preclinical research has investigated GHK-CU for its potential effects on tissue repair, wound healing, and related cellular processes. The peptide has been studied in laboratory settings for its interactions with cellular pathways involved in tissue maintenance.
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Peer-reviewed research on GHK-CU is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Important Health Information
Peptide research compounds such as GHK-CU have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
GHK-CU has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
The effects of GHK-CU on copper metabolism and homeostasis in vivo are not fully characterized. The significance of copper binding for systemic effects is not completely understood.
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
The potential systemic effects of GHK-CU and its interactions with other physiological systems are not fully understood and have not been characterized in clinical research.
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds or copper, or by those who are pregnant, nursing or have active malignancies.
The long-term effects and safety profile of GHK-CU have not been established in any population. Research on this peptide is still in the early stages.
Medical advice is particularly important for individuals with copper metabolism disorders, Wilson's disease, autoimmune conditions, or those taking medications that affect copper levels. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Common Product Questions
Quick answers about GHK-CU 10 mg specifications, storage, shipping, Bitcoin payment and general product information.
Dragon Pharma GHK-CU 10 mg is a lyophilized peptide product containing 10 mg of the copper-binding peptide GHK-CU per vial. It is supplied in a 2 mL vial for research purposes.
GHK-CU stands for glycine-histidine-lysine-copper, referring to the tripeptide sequence with a bound copper ion. It is a naturally occurring copper-binding peptide.
Each vial contains a labeled strength of 10 mg of GHK-CU.
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy GHK-CU 10 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
GHK-CU is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
Please log in to write GHK-CU 10 mg review.
Trade Name: TB 500
Compound: Thymosin Beta-4
Strength: 5 mg/vial
Form: Powder
Container: 2 mL Vial
Manufacturer: Dragon Pharma
Lab Tested: View Result
Trade Name: TB 500/BPC 157
Compound: Thymosin Beta 4, Pentadecapeptide
Strength: 10 mg/vial
Container: 2 mL Vial
Manufacturer: Dragon Pharma
Lab Tested: View Result